Maderis Gail J
Insider CIK 1503147 · OPXA Director · DRRX Director · NBY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 2,750 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 7,000 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | U Tender | 2025-09-11 | 2025-09-12 | 20,000 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | U Tender | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | M Exercise deriv | 2025-09-09 | 2025-09-11 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | M Exercise | 2025-09-09 | 2025-09-11 | 5,500 | $1.22 | $6.7K | 5,500 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-08-12 | 2022-08-12 | 25,204 | $0.71 | $17.9K | 200,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-08-11 | 2022-08-11 | 24,796 | $0.70 | $17.4K | 174,796 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-08-10 | 2022-08-11 | 79,693 | $0.69 | $55.0K | 150,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-08-09 | 2022-08-11 | 70,307 | $0.64 | $45.0K | 70,307 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2021-06-15 | 2021-06-16 | 27,500 | — | $0 | 27,500 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2021-01-04 | 2021-01-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2019-05-30 | 2019-10-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2018-05-31 | 2018-06-04 | 20,000 | — | $0 | 84,213 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2017-01-03 | 2017-01-04 | 23,883 | — | $0 | 59,769 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2016-09-30 | 2016-10-04 | 6,455 | — | $0 | 25,884 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2016-06-30 | 2016-07-01 | 6,455 | — | $0 | 19,429 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2016-05-16 | 2016-05-18 | 6,455 | — | $0 | 12,974 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2016-01-04 | 2016-01-06 | 24,777 | — | $0 | 35,886 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2015-12-31 | 2016-01-04 | 1,354 | — | $0 | 6,520 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2015-09-30 | 2015-10-02 | 1,200 | — | $0 | 5,166 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2015-06-30 | 2015-07-01 | 8,427 | — | $0 | 31,729 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 8,242 | — | $0 | 0 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 8,242 | — | $0 | 8,242 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise | 2015-04-08 | 2015-04-09 | 8,242 | — | $0 | 23,302 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2015-03-31 | 2015-04-01 | 6,818 | — | $0 | 15,060 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2015-03-30 | 2015-04-01 | 71,410 | — | $0 | 71,410 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2015-03-30 | 2015-04-01 | 23,804 | — | $0 | 23,804 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2015-01-02 | 2015-01-06 | 121,144 | — | $0 | 277,726 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2014-02-28 | 2014-03-04 | 17,686 | — | $0 | 17,686 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2014-02-28 | 2014-03-04 | 5,896 | — | $0 | 5,896 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2014-02-28 | 2014-03-04 | 8,242 | — | $0 | 8,242 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2014-01-30 | 2014-01-31 | 61,167 | — | $0 | 267,631 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2014-01-02 | 2014-01-09 | 15,000 | — | $0 | 206,464 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-04-29 | 2013-05-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-04-29 | 2013-05-01 | 17,143 | — | $0 | 17,143 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2013-01-30 | 2013-02-01 | 39,205 | — | $0 | 191,464 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2013-01-02 | 2013-01-15 | 15,000 | — | $0 | 152,259 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 20,600 | — | $0 | 20,600 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2012-01-03 | 2012-01-05 | 67,510 | — | $0 | 67,510 | SEC↗ |